**Introduction to Antimicrobial Peptide CM15** CM15 is a potent synthetic antimicrobial peptide (AMP) derived from the fusion of two natural peptides—cecropin A and melittin. Known for its broad-spectrum activity, CM15 effectively targets bacteria, fungi, and even some viruses by disrupting microbial membranes while showing minimal toxicity to mammalian cells. Its unique amphipathic structure enables selective interaction with pathogen membranes, making it a promising candidate for therapeutic and biomedical applications, including wound healing, antimicrobial coatings, and drug-resistant infection treatments. With increasing antibiotic resistance, CM15 offers a potential alternative due to its rapid action and low propensity for resistance development. Ongoing research continues to explore its clinical potential and optimization for safe, effective use.
Preparation Process: The antimicrobial peptide CM15 is prepared by solid-phase peptide synthesis (SPPS) using Fmoc chemistry. The sequence (KWKLFKKIGAVLKVL-NH2) is assembled on a Rink amide resin. Each Fmoc-protected amino acid is coupled sequentially using HBTU/HOBt/DIPEA as activators. After each coupling, the Fmoc group is deprotected with 20% piperidine/DMF. The peptide is cleaved from the resin using a mixture of TFA/TIS/water (95:2.5:2.5) for 2 hours, then precipitated in cold diethyl ether. Crude CM15 is purified via reverse-phase HPLC (C18 column, acetonitrile/water gradient) and lyophilized. Purity (>95%) is confirmed by analytical HPLC and mass spectrometry.
Usage Scenarios: CM15 is a hybrid antimicrobial peptide (AMP) derived from melittin and cecropin A, exhibiting broad-spectrum activity against bacteria, fungi, and some viruses. It disrupts microbial membranes via electrostatic interactions and pore formation, leading to cell lysis. CM15 is effective against multidrug-resistant pathogens, making it a potential alternative to conventional antibiotics. Its low cytotoxicity to mammalian cells enhances therapeutic applicability. Research explores its use in wound healing, coatings for medical devices, and as an adjuvant in antimicrobial therapies. CM15 also shows immunomodulatory effects, aiding infection control. Its stability and efficacy in diverse conditions support its development for clinical and biotechnological applications.